# Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

> **NCT03867136** · PHASE4 · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 354 (actual)

## Conditions studied

- Multidrug Resistant Tuberculosis

## Interventions

- **DRUG:** PZA sensitivity guided ultra-short all Oral Regimen
- **DRUG:** Standardized Shorter Regimen

## Key facts

- **NCT ID:** NCT03867136
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2024-08-10
- **Final completion:** 2024-08-10
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03867136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03867136, "Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03867136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*